Chimeric pestiviruses
View Patent ↗The present invention relates to chimeric pestiviruses having utility as immunogenic compositions and vaccines. Also described herein are methods and kits for treating or preventing the spread of bovine viral diarrhea virus infection, as well as methods and kits for differentiating between vaccinated and wild-type infected animals.
1. A chimeric bovine viral diarrhea virus (BVDV), that comprises pronghorn antelope pestivirus E ms protein, and lacks BVDV E ms protein.
2. A culture of the bovine viral diarrhea virus of claim 1 .
3. An isolated host cell comprising the bovine viral diarrhea virus of claim 1 .
4. A polynucleotide molecule encoding for the bovine viral diarrhea virus of claim 1 .
5. An immunogenic composition comprising the bovine viral diarrhea virus of claim 1 and a veterinarily-acceptable carrier.
6. The immunogenic composition of claim 5 , wherein the veterinarily-acceptable carrier is an adjuvant.
7. The immunogenic composition of claim 5 , wherein said bovine viral diarrhea virus is live attenuated.
8. The immunogenic composition of claim 5 , wherein said bovine viral diarrhea virus is inactivated.
9. The immunogenic composition of claim 5 , further comprising one or more additional antigens useful for treating or preventing the spread of one or more additional pathogenic microorganisms in a bovine.
10. An immunogenic composition comprising the polynucleotide molecule of claim 4 and a veterinarily-acceptable carrier.
11. A vaccine comprising the bovine viral diarrhea virus of claim 1 and a veterinarily-acceptable carrier.
12. The vaccine of claim 11 , wherein the veterinarily-acceptable carrier is an adjuvant.
13. The vaccine of claim 11 , wherein said bovine viral diarrhea virus is live attenuated.
14. The vaccine of claim 11 , wherein said bovine viral diarrhea virus is inactivated.
15. A vaccine comprising the polynucleotide molecule of claim 4 and a veterinary acceptable carrier.
16. The vaccine of claim 11 , further comprising one or more additional antigens useful for treating or preventing the spread of one or more additional pathogenic microorganisms in a bovine.
17. A kit comprising, in at least one container, the vaccine of claim 11 .
18. A method of vaccinating an animal, wherein a DIVA pestivirus vaccine is administered to said animal, and wherein said DIVA pestivirus vaccine comprises the chimeric pestivirus of claim 1 , further wherein said chimeric pestivirus has at least one E ms epitope which is not present in wild-type bovine viral diarrhea virus.
19. A method of vaccinating an animal, wherein a DIVA pestivirus vaccine is administered to said animal, and wherein said DIVA vaccine comprises the chimeric pestivirus of claim 1 , further wherein said chimeric pestivirus lacks at least one E ms epitope which is present in wild-type bovine viral diarrhea virus.
20. A diagnostic kit for differentiating between an animal vaccinated with a vaccine comprising the bovine viral diarrhea virus of claim 1 and an animal infected with wild type bovine viral diarrhea virus, said kit comprising reagents capable of detecting pronghorn antelope E ms protein which is present in the chimeric pestivirus of the vaccine, but which is not present in wild-type bovine viral diarrhea virus.
21. The chimeric virus of claim 1 , wherein the BVDV is type I.
22. The chimeric virus of claim 1 , wherein the BVDV is type II.
23. The vaccine of claim 11 , comprising chimeric type I bovine viral diarrhea virus SEQ ID NO: 31.
24. The vaccine of claim 11 , comprising chimeric type II bovine viral diarrhea virus SEQ ID NO: 32.